Skip to main content
Top
Published in: Medical Oncology 12/2017

Open Access 01-12-2017 | Review Article

Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review

Authors: Agata Dylawerska, Wojciech Barczak, Anna Wegner, Wojciech Golusinski, Wiktoria Maria Suchorska

Published in: Medical Oncology | Issue 12/2017

Login to get access

Abstract

DNA repair mechanisms allow maintain genomic stability and proper functioning within the cells. Any aberrations may cause an increased risk of many diseases such as cancer. The most crucial risk factors for head and neck squamous cell carcinoma are behavioral factors, predominantly chronic exposure to tobacco, alcohol addiction, and infection with human papillomavirus or Epstein–Barr virus. These agents can induce DNA damage; therefore, cells must activate appropriate mechanisms in order to function correctly. Cancer cells are marked with genomic instability, which is associated with a greater tendency for the accumulation of a DNA damage and increased chemo- and radioresistance. Multiple studies have assessed the correlation of increased head and neck cancer (HNC) risk with polymorphism in the DNA repair genes. However, they suggest that interaction of DNA repair genes mutations with susceptibility to HNC depends on a patient’s race and risk factors, especially tobacco smoking. Further identification of these sequence variations must be performed. In this review, we discuss the current knowledge about the DNA repair genes mutations and polymorphisms associated with the high risk of head and neck treatment.
Literature
6.
go back to reference Haines GK. Pathology of head and neck cancers I: epithelial and related tumors. In: Radosevich JA, editor. Head and neck cancer: current perspectives, advances and challenges. Dordrecht: Springer; 2013. p. 257–87.CrossRef Haines GK. Pathology of head and neck cancers I: epithelial and related tumors. In: Radosevich JA, editor. Head and neck cancer: current perspectives, advances and challenges. Dordrecht: Springer; 2013. p. 257–87.CrossRef
9.
go back to reference Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 2002;21:7435–51.CrossRefPubMed Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene. 2002;21:7435–51.CrossRefPubMed
10.
go back to reference Zhong Y, Carmella SG, Upadhyaya P, Hochalter JB, Rauch D, Oliver A, Jensen J, Hatsukami D, Wang J, Zimmerman C, Hecht SS. Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxides. Chem Res Toxicol. 2011;24:246–52. https://doi.org/10.1021/tx100345x.CrossRefPubMed Zhong Y, Carmella SG, Upadhyaya P, Hochalter JB, Rauch D, Oliver A, Jensen J, Hatsukami D, Wang J, Zimmerman C, Hecht SS. Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxides. Chem Res Toxicol. 2011;24:246–52. https://​doi.​org/​10.​1021/​tx100345x.CrossRefPubMed
12.
go back to reference Yu HP, Zhang XY, Wang XL, Shi LY, Li YY, Li F, Su YH, Wang YJ, Lu B, Sun X, Lu WH, Xu SQ. DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect Prev. 2004;28:194–9.CrossRefPubMed Yu HP, Zhang XY, Wang XL, Shi LY, Li YY, Li F, Su YH, Wang YJ, Lu B, Sun X, Lu WH, Xu SQ. DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect Prev. 2004;28:194–9.CrossRefPubMed
15.
go back to reference Scully C, Field JK, Tanzawa HB. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN) carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 2000;36:256–63.CrossRefPubMed Scully C, Field JK, Tanzawa HB. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN) carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 2000;36:256–63.CrossRefPubMed
16.
go back to reference Lindahl T, Prigent C, Barnes DE, Lehmann AR, Satoh MS, Roberts E, Nash RA, Robins P, Daly G. DNA joining in mammalian cells. Cold Spring Harb Symp Quant Biol. 1993;58:619–24.CrossRefPubMed Lindahl T, Prigent C, Barnes DE, Lehmann AR, Satoh MS, Roberts E, Nash RA, Robins P, Daly G. DNA joining in mammalian cells. Cold Spring Harb Symp Quant Biol. 1993;58:619–24.CrossRefPubMed
18.
go back to reference Reardon JT, Sancar A. Purification and characterization of Escherichia coli and human nucleotide excision repair enzyme systems. Methods Enzymol. 2006;408:189–213.CrossRefPubMed Reardon JT, Sancar A. Purification and characterization of Escherichia coli and human nucleotide excision repair enzyme systems. Methods Enzymol. 2006;408:189–213.CrossRefPubMed
19.
go back to reference Tham KC, Kanaar R, Lebbink JH. Mismatch repair and homeologous recombination. DNA Repair (Amst). 2016;38:75–83.CrossRef Tham KC, Kanaar R, Lebbink JH. Mismatch repair and homeologous recombination. DNA Repair (Amst). 2016;38:75–83.CrossRef
21.
go back to reference Plotz G, Piiper A, Wormek M, Zeuzem S, Raedle J. Analysis of the human MutLα.MutSα complex. Biochem Biophys Res Commun. 2006;340(3):852–9.CrossRefPubMed Plotz G, Piiper A, Wormek M, Zeuzem S, Raedle J. Analysis of the human MutLα.MutSα complex. Biochem Biophys Res Commun. 2006;340(3):852–9.CrossRefPubMed
22.
28.
go back to reference Cirauqui B, Margelí M, Quiroga V, Quer A, Karachaliou N, Chaib I, Ramírez JL, Muñoz A, Pollán C, Planas I, Drozdowsky A, Rosell R. DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer. Tumour Biol. 2016;37(10):13435–43.CrossRefPubMed Cirauqui B, Margelí M, Quiroga V, Quer A, Karachaliou N, Chaib I, Ramírez JL, Muñoz A, Pollán C, Planas I, Drozdowsky A, Rosell R. DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer. Tumour Biol. 2016;37(10):13435–43.CrossRefPubMed
31.
go back to reference Sossou M, Flohr-Beckhaus C, Schulz I, Daboussi F, Epe B, Radicella JP. APE1 overexpression in XRCC1-deficient cells complements the defective repair of oxidative single strand breaks but increases genomic instability. Nucleic Acids Res. 2005;33:298–306.CrossRefPubMedPubMedCentral Sossou M, Flohr-Beckhaus C, Schulz I, Daboussi F, Epe B, Radicella JP. APE1 overexpression in XRCC1-deficient cells complements the defective repair of oxidative single strand breaks but increases genomic instability. Nucleic Acids Res. 2005;33:298–306.CrossRefPubMedPubMedCentral
33.
go back to reference Mutlu P, Mutlu M, Yalcin S, Unsoy G, Yaylaci A, Saylam G, Akin I, Korkmaz H, Gunduz U. Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations. J BUON. 2015;20(2):540–7.PubMed Mutlu P, Mutlu M, Yalcin S, Unsoy G, Yaylaci A, Saylam G, Akin I, Korkmaz H, Gunduz U. Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations. J BUON. 2015;20(2):540–7.PubMed
38.
go back to reference Ruszkiewicz A, Bennett G, Moore J, Manavis J, Rudzki B, Shen L, Suthers G. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology. 2002;34(6):541–7.CrossRefPubMed Ruszkiewicz A, Bennett G, Moore J, Manavis J, Rudzki B, Shen L, Suthers G. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology. 2002;34(6):541–7.CrossRefPubMed
39.
go back to reference Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch. 2004;445(5):431–41.CrossRefPubMed Shia J, Ellis NA, Klimstra DS. The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch. 2004;445(5):431–41.CrossRefPubMed
41.
go back to reference Nogueira GA, Lourenço GJ, Oliveira CB, Marson FA, Lopes-Aguiar L, Costa EF, Lima TR, Liutti VT, Leal F, Santos VC, Rinck-Junior JA, Lima CS. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma. Int J Cancer. 2015;137(4):810–8. https://doi.org/10.1002/ijc.29435.CrossRefPubMed Nogueira GA, Lourenço GJ, Oliveira CB, Marson FA, Lopes-Aguiar L, Costa EF, Lima TR, Liutti VT, Leal F, Santos VC, Rinck-Junior JA, Lima CS. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma. Int J Cancer. 2015;137(4):810–8. https://​doi.​org/​10.​1002/​ijc.​29435.CrossRefPubMed
44.
45.
go back to reference Areeshi MY. Genetic variation in a DNA double strand break repair gene in saudi population: a comparative study with worldwide ethnic groups. Asian Pac J Cancer Prev. 2013;14:7091–4.CrossRefPubMed Areeshi MY. Genetic variation in a DNA double strand break repair gene in saudi population: a comparative study with worldwide ethnic groups. Asian Pac J Cancer Prev. 2013;14:7091–4.CrossRefPubMed
46.
go back to reference Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Müller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010;42(5):410–4. https://doi.org/10.1038/ng.569.CrossRefPubMed Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Müller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010;42(5):410–4. https://​doi.​org/​10.​1038/​ng.​569.CrossRefPubMed
47.
go back to reference Baumann P, Benson FE, West SC. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell. 1996;87(4):757–66.CrossRefPubMed Baumann P, Benson FE, West SC. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell. 1996;87(4):757–66.CrossRefPubMed
48.
go back to reference Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett. 2005;219(2):125–35.CrossRefPubMed Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett. 2005;219(2):125–35.CrossRefPubMed
50.
go back to reference Kayani MA, Khan S, Baig RM, Mahjabeen I. Association of RAD 51 135 G/C, 172 G/T and XRCC3 Thr241Met gene polymorphisms with increased risk of head andneck cancer. Asian Pac J Cancer Prev. 2014;15(23):10457–62.CrossRefPubMed Kayani MA, Khan S, Baig RM, Mahjabeen I. Association of RAD 51 135 G/C, 172 G/T and XRCC3 Thr241Met gene polymorphisms with increased risk of head andneck cancer. Asian Pac J Cancer Prev. 2014;15(23):10457–62.CrossRefPubMed
53.
go back to reference Liu MC, Gelmann EP. P53 gene mutations: case study of a clinical marker for solid tumors. Semin Oncol. 2002;29(3):246–57.CrossRefPubMed Liu MC, Gelmann EP. P53 gene mutations: case study of a clinical marker for solid tumors. Semin Oncol. 2002;29(3):246–57.CrossRefPubMed
54.
go back to reference Vinarsky V, Fine RL, Assaad A, Qian Y, Chabot JA, Su GH, Frucht H. Head and neck squamous cell carcinoma in FAMMM syndrome. Head Neck. 2009;31(11):1524–7.CrossRefPubMed Vinarsky V, Fine RL, Assaad A, Qian Y, Chabot JA, Su GH, Frucht H. Head and neck squamous cell carcinoma in FAMMM syndrome. Head Neck. 2009;31(11):1524–7.CrossRefPubMed
Metadata
Title
Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review
Authors
Agata Dylawerska
Wojciech Barczak
Anna Wegner
Wojciech Golusinski
Wiktoria Maria Suchorska
Publication date
01-12-2017
Publisher
Springer US
Published in
Medical Oncology / Issue 12/2017
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-017-1057-4

Other articles of this Issue 12/2017

Medical Oncology 12/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.